Stock Watch: Not So Fast, Gene Editors
Ground-breaking Phase I Results For Gene Editing Light An Early Fuse
Intellia’s announcement of the first in vitro gene editing proof of principle sent shockwaves through the life science investment space. But are there still many known unknowns.
